News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FRATTAROLI JOSEPH
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/23/2022 |
4
| FRATTAROLI JOSEPH (CFO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Bought 3,948 shares
@ $0.644, valued at
$2.5k
|
|
| 03/21/2022 |
4
| FRATTAROLI JOSEPH (CFO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 62,500 options to buy
@ $1.07, valued at
$66.9k
|
|
| 03/09/2022 |
4
| FRATTAROLI JOSEPH (Cheif Financial Officer) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 62,500 options to buy
@ $1.07, valued at
$66.9k
|
|
| 12/29/2020 |
4
| FRATTAROLI JOSEPH (CFO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Converted 44,143 shares
@ $10, valued at
$441.4k
Granted 100,000 options to buy
@ $10, valued at
$1M
Converted convertible notes
@ $10, valued at
$0 |
|
| 12/22/2020 |
3
| FRATTAROLI JOSEPH (CFO) has filed a Form 3 on Inhibikase Therapeutics, Inc. |
| 02/14/2006 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 02/17/2004 |
4/A
| FRATTAROLI JOSEPH (CFO) has filed a Form 4 on VASO ACTIVE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $5, valued at
$150k
|
|
| 02/13/2004 |
4
| FRATTAROLI JOSEPH (CFO) has filed a Form 4 on VASO ACTIVE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $5, valued at
$150k
|
|
|
|